Empowered Funds LLC Acquires Shares of 30,853 Astera Labs, Inc. $ALAB

Empowered Funds LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 30,853 shares of the company's stock, valued at approximately $14,903,000.

Other institutional investors and hedge funds have also modified their holdings of the company. BlackRock Inc. bought a new position in shares of Astera Labs during the second quarter worth approximately $6,609,581,000. Atreides Management LP grew its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock worth $368,890,000 after buying an additional 1,754,593 shares in the last quarter. State Street Corp increased its stake in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company's stock worth $515,684,000 after acquiring an additional 760,358 shares during the period. Geode Capital Management LLC raised its holdings in Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company's stock valued at $403,598,000 after acquiring an additional 104,935 shares in the last quarter. Finally, Bank of America Corp DE acquired a new position in Astera Labs in the 2nd quarter valued at $1,061,791,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 6,801 shares of the business's stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares in the company, valued at $32,872,551. The trade was a 6.58% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company's stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the transaction, the director directly owned 3,970 shares of the company's stock, valued at approximately $1,237,965.10. The trade was a 69.38% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 over the last 90 days. 10.40% of the stock is currently owned by company insiders.

Astera Labs Trading Down 4.8%

ALAB opened at $289.47 on Friday. The company has a market cap of $50.22 billion, a P/E ratio of 143.30 and a beta of 3.84. The company's 50 day moving average is $342.38 and its 200-day moving average is $249.65. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm's revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Jefferies Financial Group increased their target price on Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. Northland Securities raised shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 target price on the stock in a report on Monday, August 17th. TD Cowen dropped their target price on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating for the company in a research report on Wednesday, August 5th. Zacks Research upgraded shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. Finally, UBS Group restated a "neutral" rating and set a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $340.53.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source